Article
Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency.
Reumatismo - 19 Dec 2023
Ates M B, Karup S, Ugurlu S
Abstract excerpt
Deficiency of adenosine deaminase 2 (DADA2) is a recessively inherited autoinflammatory disease characterized by systemic inflammation and immunodeficiency. Infliximab proved to be favorable in the treatment of this condition. This case report is concerned with a DADA2 deficient patient treated with infliximab. This is a rare case of DADA2 in a 32-year-old female patient. The patient was admitted with a clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
